Picture of Heidelberg Pharma AG logo

HPHA — Heidelberg Pharma AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Heidelberg Pharma H1 Revenues At EUR 3.1 Mln

July 9 (Reuters) - HEIDELBERG PHARMA AG  HPHA.DE :
    * H1 SALES REVENUE AND INCOME TOTALING EUR 3.8 MILLION
    * H1 REVENUES IN AMOUNT OF EUR 3.1 MILLION (PREVIOUS YEAR:
EUR 3.8
MILLION)
    * NET LOSS FOR FIRST SIX MONTHS OF 2020 FROM EUR 4.3 MILLION
IN
PREVIOUS YEAR TO EUR 9.4 MILLION
    * CONFIRMS ITS GUIDANCE FOR CURRENT FISCAL YEAR PROVIDED ON
19
MARCH 2020.
    * H1 OTHER INCOME OF EUR 0.7 MILLION WAS HIGHER THAN
PREVIOUS
YEAR'S FIGURE OF EUR 0.3 MILLION

Source text for Eikon:  ID:nEQ2z3CqVa 
Further company coverage:  HPHA.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;;))

Recent news on Heidelberg Pharma AG

See all news